Medicinal Products for the Treatment of Blood Diseases, Hematopoietic Organs, and Cardiovascular System Diseases

This tender is for the procurement of specific medicinal products used in the treatment of cardiovascular diseases and related conditions. The procuring entity requires Dopamine concentrate for infusion solution (40 mg/ml, 5 ml ampoules) and Digoxin solution for injection (0.25 mg/ml, 1 ml ampoules). A crucial condition for participation is that the origin of the supplied goods must not be the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. Participants must also confirm the absence of outstanding obligations to the customer that led to sanctions. The procurement falls under CPV code 33620000-2 for cardiovascular system drugs. This tender ensures the availability of essential medications for patients with heart conditions and circulatory system disorders, supporting the hospital's capacity to provide critical care.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 71,655.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.